VT
ROIV icon

Vise Technologies’s Roivant Sciences ROIV Stock Holding History

Vise Technologies’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$594K Buy
16,798
+474
+3% +$14K 0.01% 1057
2026
Q1 		$354K Hold
16,324
– – 0.01% 1061
2025
Q4 		$354K Buy
+16,324
New +$322K 0.01% 1067

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vise Technologies's ROIV Position: Q2 2026 in Review

Vise Technologies increased its Roivant Sciences (ROIV) stake by 2.9% in Q2 2026, buying an estimated $14K and bringing the position to 16,798 shares worth $594K. The position accounts for 0.01% of the portfolio, ranked #1057.

Vise Technologies first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Vise Technologies held 16,798 shares of Roivant Sciences worth $594K as of Q2 2026.
  • Vise Technologies bought 474 Roivant Sciences shares in Q2 2026, an estimated $14K.
  • Roivant Sciences made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #1057 holding.
  • Vise Technologies first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.